Effectiveness of Sealants and Fluoride Varnish in Caries Prevention in Children With Autism Spectrum Disorders

Sponsor
University of Milan (Other)
Overall Status
Completed
CT.gov ID
NCT05146479
Collaborator
(none)
232
1
185.9
1.2

Study Details

Study Description

Brief Summary

The aim of the study is to compare application of sealants together with fluoride varnishes versus only fluoride varnishes in preventing caries lesions development in the occlusal surface of first permanent molars of children with ASDs.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Fluoride varnish and pit and fissure sealants onto first permanent molars

Detailed Description

The aim of the study is to evaluate if the application of pit and fissure sealants together with fluoride varnishes is more effective than the application of the only fluoride varnishes in preventing caries lesions development in the occlusal surface of first permanent molars of children with ASDs.

Patients with at least 10-year follow-up and ASDs are recruited and allocated to two cohort according to the strategy adopted for prevention of caries in first permanent molars: FA group (only fluoride varnishes) and FA+S group (sealants together with fluoride varnishes).

Caries incidence and sealants retention after the follow-up period are recorded. Demographic and clinical characteristics of patients at first dental visit are also recorded (age, level of cooperation, presence of systemic diseases other than ASDs, caries severity) to evaluate if they play a potential protective and/or risk factors for caries development.

Logistic and multivariate analysis are run to evaluate caries incidence and retention rate of sealants in first permanent molars over a period of at least 10 years.

Study Design

Study Type:
Observational
Actual Enrollment :
232 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
A Long-term Retrospective Cohort Study in Children With Autism Spectrum Disorders on the Effectiveness of Dental Sealants and Fluoride Varnish to Prevent the Occurrence of New Caries
Actual Study Start Date :
Jan 1, 2006
Actual Primary Completion Date :
Jun 30, 2021
Actual Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Fluoride varnish (FA group)

Application of 5% NaF varnish onto first permanent molars

Fluoride varnish + dental sealant (FA+S group)

Application of 5% NaF varnish plus pit and fissure sealant onto first permanent molars

Procedure: Fluoride varnish and pit and fissure sealants onto first permanent molars
Quarterly application of fluoride varnish. Application of pit and fissure sealant, and replacements if necessary.

Outcome Measures

Primary Outcome Measures

  1. Survival rates from dental caries [15 years]

    Percentage of first permanent molars free from caries

Secondary Outcome Measures

  1. Survival rates of pit and fissure sealant [15 years]

    Percentage of pit and fissure sealant sound

  2. Evaluation of confounders [15 years]

    Evaluation if patient's variables at the first dental visit, such as age, number of dental caries, cooperation level, are positively or negatively associated with first permanent molars decay rates overtime.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASDs

  • age less than 14 years

  • written declaration of informed consent signed by parents/guardians

Exclusion Criteria:
  • incomplete clinical records

  • missing five or more dental check-ups over the follow-up period

  • oral or dental care provided in sedation or general anesthesia

  • follow-up less than 15 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dental Clinic San Paolo Hospital Milan Italy 20142

Sponsors and Collaborators

  • University of Milan

Investigators

  • Study Chair: Maria Grazia MG Cagetti, Prof, University of Milan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maria Grazia Cagetti, Prof. Maria Grazia Cagetti, University of Milan
ClinicalTrials.gov Identifier:
NCT05146479
Other Study ID Numbers:
  • 0000546
First Posted:
Dec 6, 2021
Last Update Posted:
Dec 21, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Maria Grazia Cagetti, Prof. Maria Grazia Cagetti, University of Milan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 21, 2021